chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Reaction at injection site - appeared almost 36 hours after receiving the 2nd dose on 4/28 - the site was already painful and became warm, red, swollen. The warm, red, swollen area has slowly gotten larger and is now roughly the size of a lemon.
Symptoms within 24 hours, chills,  sweats, nausea, fever up to 103.1.
Lightheaded/Dizziness, BP 103/65, HR 70, SpO2 95%
Started with a sore throat the first evening.  Next day, stilll sore throat but itchy / scratchy throat, achy body, heachache and stuffy nose.
unable to administer full 0.5 mL to patient. Tried miltiple syringes, needles, etc. Having no trouble administering other vaccines/ No AE; unable to administer full 0.5 mL to patient. Tried multiple syringes, needles, etc. Having no trouble administering other vaccines/ No AE; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves patient who unable to administer full 0.5 ml vaccine INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] lot number not reported via unknown route in unknown administration site on an unknown date, tried multiple syringes, needles.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of vaccine underdose and Liquid product flow abnormal. Staff unable to administer full 0.5 mL to patient. Tried multiple syringes, needles, etc. Having no trouble administering other vaccines.  At the time of report no adverse event was reported.  Information on the batch number was requested.  Documents held by sender: none.
(2nd dose) residual aching legs very regularly; (2nd dose) swollen upper arm; (2nd dose) painful upper arm; Injection site was so painfull; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY ((2nd dose) residual aching legs very regularly), PERIPHERAL SWELLING ((2nd dose) swollen upper arm), PAIN IN EXTREMITY ((2nd dose) painful upper arm) and INJECTION SITE PAIN (Injection site was so painfull) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY ((2nd dose) residual aching legs very regularly), PERIPHERAL SWELLING ((2nd dose) swollen upper arm), PAIN IN EXTREMITY ((2nd dose) painful upper arm) and INJECTION SITE PAIN (Injection site was so painfull). At the time of the report, PAIN IN EXTREMITY ((2nd dose) residual aching legs very regularly) had not resolved, PERIPHERAL SWELLING ((2nd dose) swollen upper arm) had resolved and PAIN IN EXTREMITY ((2nd dose) painful upper arm) and INJECTION SITE PAIN (Injection site was so painfull) outcome was unknown.            The unspecified concomitant medication was reported for high blood pressure.  On an unknown date, after the second vaccination, the patient had residual aching legs all the time. The patient had swollen upper arm which was painful after vaccination and lasted about an week.   This case was linked to MOD-2021-275262 (Patient Link).
fever started 10AUG95 100;12AUG95 T104;ax rash began 12AUG95;rash on back, chest & face (red, pinpoint rash);pt cranky;fever did not respond to APAP did respond to Advil alternated w/APAP;MD visit sl red throat & eyes
Patient came in to get 3rd booster dose for immunocompromised patient by guidelines brought by the board of pharmacy of the state. patient filled out form online and brought in. The patient had never filled at our pharmacy and didn't bring vaccine card. Patient stated they previously got Moderna  verbally and on form that was filled out. 3rd dose of Moderna was administered,  and was later discovered patient received pfizer for previous two shots. Alert was printed, but was missed by the pharmacist.
Information has been received from a nurse practitioner concerning a 24 year old female with penicillin allergy and allergic reaction to antibiotics who on an unspecified date was vaccinated with a first dose of GARDASIL vaccine (yeast) IM. On 20-JUN-2008, the now 25 year old patient was vaccinated with a second dose of GARDASIL vaccine (yeast) IM. Concomitant therapy included "Mercet birth control" (hormonal contraceptives (unspecified)). The patient was unable to lift her arm above shoulder level after being immunized with the second dose of GARDASIL vaccine (yeast). The patient also suffered from severe bilateral back pain after receiving the second dose of GARDASIL vaccine (yeast). The nurse practitioner reported that the patient had experienced mild symptoms after the first dose of GARDASIL vaccine (yeast), but the symptoms were much more pronounced with the second dose. The nurse practitioner reported that the patient was seen in the office on 23-JUN-2008 and was treated with acetaminophen (TYLENOL) for the pain. Additional information has been requested. This is in follow-up to report (s) previously submitted on 7/15/2008. Information has been received from a nurse practitioner concerning a 24 year old registered nurse with penicillin allergy and allergice reaction to antibiotics who on approximately 14-APR-2008 was vaccinated with a first dose of GARDASIL vaccine IM. At 6pm on 14-APR-2008 the patient experienced pain in shoulder of injection site radiating down arm and severe low back pain within 6 hours. On 20-JUN-2008, the now 25 year old patient was vaccinated with a second dose of GARDASIL vaccine (lot# 060391/0063X) IM in her right deltoid. Concomitant therapy included "MERCET birth control" (unspecified). The patient experienced pain in her shoulder of the injection site radiating down her arm and severe bilateral back pain which continued for 2 weeks. The symptoms were much more pronounced with the second dose. The patient was unable to lift her arm above shoulder level after being immunized with the second dose of GARDASIL vaccine. The nurse preactitioner reported that the patient was seen in the office on 23-JUN-2008 and was treated with TYLENOL, prednisone (manufacturer unknown), cyclobenzaprine hydrochloride (MSD) and PERCOCET for the pain. The patient recovered. Additional information is not expected.
Alopecia areata just after second Covid Moderna shot, which caused severe flu-like symptoms for 48 hours after the shot was administered.
Initial unsolicited report received from a consumer (patient's mother) via sales representative on 10 Nov 2016. This case involves a male patient (age was not reported) who was vaccinated with a dose of INFLUENZA VACCINE (batch number, expiration date, route, dose not reported) on 31 Oct 2016 and a dose of PNEUMOCOCCAL VACCINE on an unspecified date (reported as vaccinated two weeks before flu shot). Patient's pre-existing physician diagnosed allergies, birth defects was not reported and ongoing medical conditions included Type III Gaucher disease. Concomitant medications include CZ [Cerezyme]. It was also reported that patient was on high dose of Cerezyme (6000 units Q2 weeks). Some medications of patient's was adjusted. On 02 Nov 2016, two days following flu vaccination and unspecified timeframe after pneumonia vaccine, the patient experienced seizure. Lab data was not reported and patient received Lamictal from 150 mg to 200 mg every night along with Depakote as corrective treatment. The patient's event outcome was not reported. The case was reported as serious be reporter. List of documents held by sender: none. Sender's Comments: This case concerns a male patient who had a seizure, two days after receiving a dose of INFLUENZA VACCINE. It was reported that the patient had received PNEUMOCOCCAL VACCINE two weeks before his flu shot. The patient has a history of Type 3 Gaucher disease and on treatment with anticonvulsants. Details such as, event information, previous immunization history and tolerance, patient immune status at the time of vaccination and reporter causality are not reported. As multiple vaccines are administered the role of each vaccine cannot be assessed and based on the medical history, the role of vaccine is unlikely.
Fever which went high up to 101.3.; She felt tired and worn out; Bodyaches; She felt crummy; Tired; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (She felt crummy), FATIGUE (Tired), MYALGIA (Bodyaches) and PYREXIA (Fever which went high up to 101.3.) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired). On 28-Feb-2021, the patient experienced FEELING ABNORMAL (She felt crummy). On 01-Mar-2021, the patient experienced MYALGIA (Bodyaches). On 02-Mar-2021, the patient experienced PYREXIA (Fever which went high up to 101.3.) and FATIGUE (She felt tired and worn out). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Feb-2021, PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired) had resolved. On 02-Mar-2021, FEELING ABNORMAL (She felt crummy), MYALGIA (Bodyaches), PYREXIA (Fever which went high up to 101.3.) and FATIGUE (She felt tired and worn out) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Pyrexia: 101.3 (High) recovered on 02mar2021.         Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Action item updated to Patient denied FU
reaction to pneumovax; pain from her arm to her chest after getting vaccine, having serious pain and swollen arm and headaches pain traveled up to her neck; pain from her arm to her chest after getting vaccine, having serious pain and swollen arm and headaches pain traveled up to her neck; pain from her arm to her chest after getting vaccine, having serious pain and swollen arm and headaches pain traveled up to her neck; pain from her arm to her chest after getting vaccine, having serious pain and swollen arm and headaches pain traveled up to her neck; pain from her arm to her chest after getting vaccine, having serious pain and swollen arm and headaches pain traveled up to her neck; This spontaneous report as received from a physician via a company representative refers to a 65-year-old female patient. The patient's medical history and concurrent conditions were not reported. However, it was reported that the patient experienced reaction to pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) on an unknown date.  On 09-SEP-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose number, route of administration and dose volume were not reported) for pneumonia prophylaxis.        On 10-SEP-2020, after getting the vaccine, the patient experienced pain from her arm to her chest, having serious pain and swollen arm and headaches pain traveled up to her neck. The patient's outcome was not reported. Causality between the event of arm pain, chest pain, swollen arm, headache and neck pain was not reported. Causality between unspecified reaction to pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and the vaccination with reaction to pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was assessed as related.  The reporting physician considered pain from her arm to her chest, having serious pain and swollen arm and headaches pain traveled up to her neck to be serious (medically significant).
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium.
By the evening of the day of shot, shoulder lost a lot of mobility and could not put my arm to the side or up.    I experienced a lot of pain in the back of the joint at the rotator cuff.  I could not put a glass on a table, for example.   The shot was administered very high on the shoulder. It seemed to be more in the joint. I did not have any pain in my deltoid muscle.   This lasted for a few weeks and progressively improved.
Roughly 36 hours after vaccination developed unilateral angioedema of the upper lip, which despite antihistamines (benadryl and H1) spread across to upper and lower lips bilaterally.  No orolingual edema, wheezing, urticaria, etc.   Despite scheduled antihistamines (50 mg benadryl q6) only somewhat better today (24 hrs after onset).  No history of any angioedema in past or significant food, environmental, or medication allergy (an no family of HAE).  Has been on his low dose ACE inhibitor for decades.
I received my Pfizer vaccine at about noon or so on 4/4/2021. On 4/5/2021 at about 10:00PM, I went to work. I began to feel weird. My left arm began tingling and went numb. The numbness came and went, and I just chalked it up to the fact that I have a metal plate in my left shoulder. I thought that maybe I had just moved my arm the wrong way.  On 4/6/2021 in the early evening, the back of my head began tingling. The left side of my face and my left arm became numb, and I developed a severe headache.   A few days after I got the vaccine, I developed a whooshing sound in my ears, which continues off and on to this day. The only time it has ever stopped completely was when I got COVID-19 in September. After I recovered, the sound recovered, though it wasn't as severe as it was before I got the virus.   On the night of 4/16/2021, I went to the ER. I went when the numbness returned and affected the left side of my face and my left arm. Also, the back of my head tingled, and my left leg felt weak. I underwent various tests, including an MRI and bloodwork. It was noted on my chart that I was having potential transient ischemic attacks.   On 5/19/2021, I went to a neurologist doctor. He read the MRI results from the ER and scheduled me for an MRA of my head and an MRI of my neck. After I underwent those tests, I was told I had a partial blockage of the right carotid artery and that it was the possible cause of the tingling and numbness. The cause of the blockage is unknown, as my cholesterol levels are normal. I am scheduled to see a radiologist on 11/18/2021. If the blockage is severe enough, I will have a stent put in.
Patient presented 9/1/17 with whelps on left shoulder and collarbone, soreness down left shoulder and neck, and swollen neck on left side. Patient said she received Flu and Pneumonia both 8/30/17 in the same arm. Patient said she was going to the doctor to let them check her out and make sure it was a reaction to the shot and nothing else. Patient called and let us know that the doctor decided it was just a localized reaction and gave her a TORADOL injection along with another injection she didn't know the name of. The doctor said it was given high in the arm.
itchy rash; little red bumps; rash appeared first in the forearm and the expanded to the whole arm (but it was a lighter rash); in the legs; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (itchy rash), INJECTION SITE MASS (little red bumps), RASH (rash appeared first in the forearm and the expanded to the whole arm (but it was a lighter rash)) and RASH (in the legs) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, the patient experienced RASH PRURITIC (itchy rash), INJECTION SITE MASS (little red bumps), RASH (rash appeared first in the forearm and the expanded to the whole arm (but it was a lighter rash)) and RASH (in the legs). The patient was treated with CETIRIZINE HYDROCHLORIDE (ALLERCET) at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (itchy rash), INJECTION SITE MASS (little red bumps), RASH (rash appeared first in the forearm and the expanded to the whole arm (but it was a lighter rash)) and RASH (in the legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication provided
Fever 101 evening of 10-25-06. Rash on left arm (shot administered) 10-26-06 - 10-27-06
As soon as I got the shot I had a medal taste in my mouth. Then a few minutes later my mouth felt tight  but wasn't swollen. The facility had me stay for about 40 minutes. Nothing got worse. Last night I discovered 2 ulcers in my mouth and was very tired. This morning I have diarrhea and its a yellow color. Ulcers are still in my mouth and occasionally I taste a medal taste.
Received vaccine 9/13/02 L deltoid. 9/14 arm sore ; 9/15 swollen and sore shoulder to elbow, couldn't move arm, went to ER, unsucessful attempt to drain possible abscess. 9/16: more pain, edema, erythema, febrile. Saw personal MD: IM rocephin and now on oral antibiotics and activity restriction x 6 days. 9/17: still red, sore, edema is decreasing, afebrile.
Excruciating pain couldn't lift my arm even nor can I lift anything in that hand such as jug of milk.
Developed intussusception 5 days after initial dose of ROTATEQ on 6-16-14.
non-itchy, bumpy rash on right forearm; cold progressed; sinus infection; cough; This case was reported by a consumer via call center representative and described the occurrence of cold in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included sinus infection, shingles and bronchitis. Concurrent medical conditions included runny nose and common cold.   On 24th October 2022, the patient received the 2nd dose of Shingrix (intramuscular). On 24th October 2022, less than a day after receiving Shingrix, the patient experienced cold, sinus infection and cough. On 27th October 2022, the patient experienced papular rash. The patient was treated with antibiotics nos (Antibiotic (Active Ingredient Unknown)). On an unknown date, the outcome of the cold, sinus infection, cough and papular rash were not recovered/not resolved.   It was unknown if the reporter considered the cold, sinus infection, cough and papular rash to be related to Shingrix.     Additional Information: GSK Receipt Date: 27-OCT-2022 Reporter's Comment: The patient was the reporter.  The patient received her second Shingrix dose in her right deltoid on 24-OCT-2022.  The reporter mentioned prior to the vaccination she had a runny nose and a cold.  After the vaccination, on 24-OCT-2022, the cold progressed and she developed a sinus infection and cough. The patient's physician was prescribed an unknown antibiotic to treat the sinus infection.  On 27-OCT-2022, she developed a non-itchy, bumpy rash on her right forearm. The reporter give consent to follow up.
BODY ACHES; FEELING HOT; BAD HEADACHE; his spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced body aches, feeling hot, and bad headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body aches, feeling hot and bad headache was not reported. This report was non-serious. This case, from the same reporter is linked to 20210420044 and 20210421304.
The patient was in the Pharmacy today to get his flu shot, during the visit he mentioned that the last time he was in this specific store, he received a vaccine and developed a bump that didn't go away. He showed it to me and it looked like the area is still puffy with a scar. He mentioned it does not bother him but thought it would go away when he consulted with the male Pharmacist a few days after. He never informed his doctor but says he will mention it next time he sees him.
Patient experienced burning sensation on the left side of her upper torso, throat and chest as well in her mouth which she described as a "taste" that burned.. (vaccine was injected into the left deltoid).  She also experienced extreme flushing of the face and chest. These symptoms lasted for approximately ten minutes and then subsided.
A report was received from a health care professional on 11/21/2002 concerning eleven vaccinees between the ages of 56 and 64 years who were inadvertently administered 1ml Fluvirin on an unreported date. On an unreported date eleven vaccinees were inadvertently administered 1ml Fluvirin, No adverse reaction was reported. There was insufficient information to determine the reporters causality assessment. Update1. 12/31/2002: A Follow up report was received from a health care professional indicated that a 74 year old male vaccinee was inadvertently administered 1.0ml Fluvirin on 11/21/2002. Cross Reference with: PJP200200806, PJP200200906, PJP200200905, PJP200200904, PJP200200903, PJP200200902, PJP200200901, PJP200200899, PJP200200898, PJP200200907.
h/a 2PM, arm sore by 10PM overall body ache 2AM;elevated temp 101 by 24hrs p/vax; inc body ache-upper body, not confined to arm-neck, shoulder etc, in bed @ 48hrs-72hrs
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: 21-SEP-2021) dose was not reported, administered on 07-OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-OCT-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20220136393.